P

Pulike Biological Engineering Inc
SSE:603566

Watchlist Manager
Pulike Biological Engineering Inc
SSE:603566
Watchlist
Price: 13.19 CNY -3.01% Market Closed
Market Cap: 4.5B CNY
Have any thoughts about
Pulike Biological Engineering Inc?
Write Note

Pulike Biological Engineering Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pulike Biological Engineering Inc
Operating Income Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
P
Pulike Biological Engineering Inc
SSE:603566
Operating Income
ÂĄ124m
CAGR 3-Years
-21%
CAGR 5-Years
4%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Income
ÂĄ2.6B
CAGR 3-Years
-2%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Operating Income
ÂĄ3.4B
CAGR 3-Years
17%
CAGR 5-Years
20%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Income
ÂĄ5.8B
CAGR 3-Years
-4%
CAGR 5-Years
4%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Income
ÂĄ4B
CAGR 3-Years
-1%
CAGR 5-Years
14%
CAGR 10-Years
3%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Operating Income
-ÂĄ749.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pulike Biological Engineering Inc's Operating Income?
Operating Income
124m CNY

Based on the financial report for Jun 30, 2024, Pulike Biological Engineering Inc's Operating Income amounts to 124m CNY.

What is Pulike Biological Engineering Inc's Operating Income growth rate?
Operating Income CAGR 5Y
4%

Over the last year, the Operating Income growth was -49%. The average annual Operating Income growth rates for Pulike Biological Engineering Inc have been -21% over the past three years , 4% over the past five years .

Back to Top